• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受连续性肾脏替代治疗(CRRT)的重症患者的抗生素给药:给药不足极为普遍。

Antibiotic dosing in critically ill patients receiving CRRT: underdosing is overprevalent.

作者信息

Lewis Susan J, Mueller Bruce A

机构信息

Department of Clinical Social and Administrative Sciences, University of Michigan College of Pharmacy, Ann Arbor, Michigan.

出版信息

Semin Dial. 2014 Sep-Oct;27(5):441-5. doi: 10.1111/sdi.12203.

DOI:10.1111/sdi.12203
PMID:25204875
Abstract

Published CRRT drug dosing algorithms and other dosing guidelines appear to result in underdosed antibiotics, leading to failure to attain pharmacodynamic targets. High mortality rates persist with inadequate antibiotic therapy as the most important risk factor for death. Reasons for unintended antibiotic underdosing in patients receiving CRRT are many. Underdosing may result from lack of the recognition that better hepatic function in AKI patients yields higher nonrenal antibiotic clearance compared to ESRD patients. Other factors include the variability in body size and fluid composition of patients, the serious consequence of delayed achievement of antibiotic pharmacodynamic targets in septic patients, potential subtherapeutic antibiotic concentrations at the infection site, and the influence of RRT intensity on antibiotic concentrations. Too often, clinicians weigh the benefits of overcautious antibiotic dosing to avoid antibiotic toxicity too heavily against the benefits of rapid attainment of therapeutic antibiotic concentrations in critically ill patients receiving CRRT. We urge clinicians to prescribe antibiotics aggressively for these vulnerable patients.

摘要

已发表的连续性肾脏替代治疗(CRRT)药物给药算法及其他给药指南似乎会导致抗生素剂量不足,从而无法达到药效学目标。抗生素治疗不足作为死亡的最重要风险因素,高死亡率持续存在。接受CRRT的患者出现意外抗生素剂量不足的原因有很多。剂量不足可能是由于未认识到急性肾损伤(AKI)患者比终末期肾病(ESRD)患者具有更好的肝功能,从而产生更高的非肾脏抗生素清除率。其他因素包括患者体型和体液成分的变异性、脓毒症患者延迟达到抗生素药效学目标的严重后果、感染部位潜在的亚治疗性抗生素浓度以及肾脏替代治疗强度对抗生素浓度的影响。临床医生常常过于看重谨慎使用抗生素以避免抗生素毒性的益处,而相对忽视了在接受CRRT的重症患者中迅速达到治疗性抗生素浓度的益处。我们敦促临床医生为这些脆弱的患者积极开具抗生素处方。

相似文献

1
Antibiotic dosing in critically ill patients receiving CRRT: underdosing is overprevalent.接受连续性肾脏替代治疗(CRRT)的重症患者的抗生素给药:给药不足极为普遍。
Semin Dial. 2014 Sep-Oct;27(5):441-5. doi: 10.1111/sdi.12203.
2
Antibiotic Dosing in Patients With Acute Kidney Injury: "Enough But Not Too Much".急性肾损伤患者的抗生素给药:“足够但不过量”
J Intensive Care Med. 2016 Mar;31(3):164-76. doi: 10.1177/0885066614555490. Epub 2014 Oct 16.
3
We Underdose Antibiotics in Patients on CRRT.我们对接受连续性肾脏替代治疗(CRRT)的患者抗生素用药剂量不足。
Semin Dial. 2016 Jul;29(4):278-80. doi: 10.1111/sdi.12496. Epub 2016 Apr 15.
4
SaMpling Antibiotics in Renal Replacement Therapy (SMARRT): an observational pharmacokinetic study in critically ill patients.肾脏替代治疗中抗生素的采样(SMARRT):一项针对危重症患者的观察性药代动力学研究。
BMC Infect Dis. 2016 Mar 1;16:103. doi: 10.1186/s12879-016-1421-6.
5
The influence of acute kidney injury on antimicrobial dosing in critically ill patients: are dose reductions always necessary?急性肾损伤对重症患者抗菌药物剂量的影响:是否总是需要降低剂量?
Diagn Microbiol Infect Dis. 2014 May;79(1):77-84. doi: 10.1016/j.diagmicrobio.2014.01.015. Epub 2014 Jan 24.
6
Antibiotic dosing in critically ill patients with acute kidney injury.危重症急性肾损伤患者的抗生素给药。
Nat Rev Nephrol. 2011 Apr;7(4):226-35. doi: 10.1038/nrneph.2011.12. Epub 2011 Feb 22.
7
[Antibiotic dose adjustment in the treatment of MRSA infections in patients with acute renal failure undergoing continuous renal replacement therapies].[接受持续肾脏替代治疗的急性肾衰竭患者耐甲氧西林金黄色葡萄球菌感染治疗中的抗生素剂量调整]
Enferm Infecc Microbiol Clin. 2012 May;30(5):249-56. doi: 10.1016/j.eimc.2011.09.013. Epub 2011 Nov 29.
8
Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy.接受持续肾脏替代治疗的重症成年患者的抗生素给药
Clin Infect Dis. 2005 Oct 15;41(8):1159-66. doi: 10.1086/444500. Epub 2005 Sep 12.
9
Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study.连续性肾脏替代治疗的危重症患者的抗生素浓度变异性:一项多中心药代动力学研究。
Crit Care Med. 2012 May;40(5):1523-8. doi: 10.1097/CCM.0b013e318241e553.
10
How can we ensure effective antibiotic dosing in critically ill patients receiving different types of renal replacement therapy?对于接受不同类型肾脏替代治疗的重症患者,我们如何确保有效的抗生素给药剂量?
Diagn Microbiol Infect Dis. 2015 May;82(1):92-103. doi: 10.1016/j.diagmicrobio.2015.01.013. Epub 2015 Feb 2.

引用本文的文献

1
Vancomycin administration and AUC/MIC in patients with acute kidney injury on hemodialysis (HD): randomized clinical trial.血液透析(HD)急性肾损伤患者的万古霉素给药及AUC/MIC:随机临床试验
Sci Rep. 2024 Dec 28;14(1):31220. doi: 10.1038/s41598-024-82587-1.
2
Reducing hydrophobic drug adsorption in an in-vitro extracorporeal membrane oxygenation model.减少体外膜肺氧合模型中疏水药物的吸附。
Eur J Pharm Biopharm. 2024 May;198:114261. doi: 10.1016/j.ejpb.2024.114261. Epub 2024 Mar 14.
3
Medication patterns and dosing guidance in pediatric patients supported with intermittent hemodialysis or continuous kidney replacement therapy.
接受间歇性血液透析或连续性肾脏替代治疗的儿科患者的用药模式及给药指导。
Pediatr Nephrol. 2024 May;39(5):1521-1532. doi: 10.1007/s00467-023-06199-z. Epub 2023 Dec 5.
4
Impact of renal replacement therapy strategy on beta-lactam plasma concentrations: the BETAKIKI study-an ancillary study of a randomized controlled trial.肾脏替代治疗策略对β-内酰胺类药物血浆浓度的影响:BETAKIKI研究——一项随机对照试验的辅助研究
Ann Intensive Care. 2023 Feb 25;13(1):11. doi: 10.1186/s13613-023-01105-0.
5
Optimizing Antimicrobial Dosing for Critically Ill Patients with MRSA Infections: A New Paradigm for Improving Efficacy during Continuous Renal Replacement Therapy.优化耐甲氧西林金黄色葡萄球菌感染重症患者的抗菌药物剂量:持续肾脏替代治疗期间提高疗效的新范例
Pharmaceutics. 2022 Apr 11;14(4):842. doi: 10.3390/pharmaceutics14040842.
6
Beta-lactam dosing during continuous renal replacement therapy: a survey of practices in french intensive care units.β-内酰胺类药物在连续性肾脏替代治疗中的剂量:法国重症监护病房实践调查。
BMC Nephrol. 2022 Jan 29;23(1):48. doi: 10.1186/s12882-022-02678-x.
7
Size Matters: The Influence of Patient Size on Antibiotics Exposure Profiles in Critically Ill Patients on Continuous Renal Replacement Therapy.体型很重要:持续肾脏替代治疗的危重症患者体型对抗生素暴露情况的影响
Antibiotics (Basel). 2021 Nov 12;10(11):1390. doi: 10.3390/antibiotics10111390.
8
Commentary: Recommendation of Antimicrobial Dosing Optimization During Continuous Renal Replacement Therapy.述评:连续性肾脏替代治疗期间抗菌药物剂量优化的推荐意见
Front Pharmacol. 2020 Sep 16;11:580163. doi: 10.3389/fphar.2020.580163. eCollection 2020.
9
Some Suggestions from PK/PD Principles to Contain Resistance in the Clinical Setting-Focus on ICU Patients and Gram-Negative Strains.从药代动力学/药效学原理出发控制临床耐药性的若干建议——聚焦于重症监护病房患者及革兰氏阴性菌
Antibiotics (Basel). 2020 Oct 6;9(10):676. doi: 10.3390/antibiotics9100676.
10
Vancomycin for Dialytic Therapy in Critically Ill Patients: Analysis of Its Reduction and the Factors Associated with Subtherapeutic Concentrations.万古霉素在危重症患者透析治疗中的应用:降阶梯治疗分析及与治疗浓度不达标的相关因素。
Int J Environ Res Public Health. 2020 Sep 19;17(18):6861. doi: 10.3390/ijerph17186861.